English

• 15 Apr, 2025
  Spago Nanomedical publishes the annual report for 2024
• 9 Apr, 2025
  NOTICE TO ANNUAL GENERAL MEETING OF SPAGO NANOMEDICAL AB (PUBL)
• 20 Mar, 2025
  Nomination committee’s proposal for a new chairman and composition of Spago Nanomedical’s board
• 4 Mar, 2025
  Spago Nanomedical proceeds with increased dose in the phase I/IIa study Tumorad-01
• 6 Feb, 2025
  Spago Nanomedical year-end report January-December, 2024
• 15 Jan, 2025
  Spago Nanomedical article on SPAGOPIX-01 clinical results accepted for publication in Investigative Radiology
• 18 Dec, 2024
  Second patient group successfully dosed in Spago Nanomedical’s Phase I/IIa study Tumorad-01
• 6 Nov, 2024
  Spago Nanomedical interim report January-September 2024
• 21 Oct, 2024
  Nomination committee appointed for Spago Nanomedical’s Annual General Meeting 2025
• 1 Oct, 2024
  Spago Nanomedical in new phase with full focus on the Tumorad program